RE:RE:RE:RE:Immune cell that can kill most cancersNo expert but it appears that the potential advance here is in respect of the breadth of indications that might be treatable and the avoidance of a current hugely-expensive requirement to individually personalise.
They`ve said that their indicative preclinical work has returned results that are on a par with present CAR-T so in terms of efficacy it will have to be seen whether it might actually be superior - and current CAR -T is far from universally efficacious.
Then there are cancers to which this will be totally inapplicable.
In short it is far more important for us that TLT`s Trial runs as we hope than what others may be doing.